Overview
Multicentric prospective study with collection of biological samples as part of type II research
Eligibility
Inclusion Criteria:
- Patient with cancer who will start treatment anticancer (see cohorts).
- Patient information and signature of the consent form before any specific procedure for the study. The patient must be able and must be inclined to cooperate in the study procedures.
- Patient affiliated to a social security scheme or beneficiary of a similar scheme.
Exclusion Criteria:
- Pregnant or lactating woman
- Patient under guardianship or curatorship or deprived of liberty by a decision judicial or administrative or patient unable to give his consent.
